Pulmonary Arterial Elastance and INTERMACS-Defined Right Heart Failure Following Left Ventricular Assist Device

Author:

Muslem Rahatullah1,Ong Chin S.2,Tomashitis Brett3,Schultz Jessica4,Ramu Bhavadharini3,Craig Michael L.3,Van Bakel Adrian B.3,Gilotra Nisha A.5,Sharma Kavita5,Hsu Steven5,Whitman Glenn J.2,Leary Peter J.6,Cogswell Rebecca4,Lozonschi Lucian7,Houston Brian A.3,Zijlstra Felix1,Caliskan Kadir1,Bogers Ad J.J.C.8,Tedford Ryan J.3

Affiliation:

1. Department of Cardiology (R.M., F.Z., K.C.), Erasmus MC, University Medical Center Rotterdam, the Netherlands.

2. Department of Cardiac Surgery, Johns Hopkins School of Medicine, Baltimore, MD (C.S.O., G.L.W.).

3. Division of Cardiology, Department of Medicine (B.T., B.R., M.L.C., A.B.V.B., B.A.H., R.J.T.), Medical University of South Carolina, Charleston.

4. Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis (J.S., R.C.).

5. Division of Cardiology, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD (N.A.G., K.S., S.H.).

6. Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle (P.J.L.).

7. Department of Cardiothoracic Surgery (L.L.), Medical University of South Carolina, Charleston.

8. Department of Cardiothoracic Surgery (A.J.J.C.B.), Erasmus MC, University Medical Center Rotterdam, the Netherlands.

Abstract

Background: Acute right heart failure (RHF) after left ventricular assist device implantation remains a major source of morbidity and mortality, yet the definition of RHF and the preimplant variables that predict RHF remain controversial. This study evaluated the ability of (1) INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) RHF classification to predict post-left ventricular assist device survival and (2) preoperative characteristics and hemodynamic parameters to predict severe and severe acute RHF. Methods and Results: An international, multicenter study at 4 large academic centers was conducted between 2008 and 2016. All subjects with hemodynamics measured by right heart catheterization within 30 days before left ventricular assist device implantation were included. RHF was defined using the INTERMACS definition for RHF. In total, 375 subjects were included (mean age, 57.4±13.2 years, 54% bridge-to-transplant). Mild RHF was most common (34%), followed by moderate RHF (16%), severe RHF (13%), and severe acute RHF (9%). Estimated on-device survival rates at 2 years were 72%, 71%, and 55% in the patients with none, mild-to-moderate, and severe-to-severe acute RHF, respectively ( P =0.004). In addition, the independent hazard ratio for mortality was only increased in the patients with severe-to-severe acute RHF (hazard ratio, 3.95; 95% CI, 2.16–7.23; P <0.001). INTERMACS-defined RHF was superior to postimplant inotrope duration alone in the prediction of all-cause mortality. In multivariable analysis, older age, lower INTERMACS classes, and higher pulmonary arterial elastance (ratio of systolic pulmonary artery pressure to stroke volume) before left ventricular assist device, were identified as significant predictors of severe-to-severe acute RHF. Stratifying patients by ratio of systolic pulmonary artery pressure to stroke volume and right atrial pressure significantly improved the discrimination between patients at risk for severe-to-severe acute RHF. Conclusions: The INTERMACS RHF classification correctly identifies patients at risk for mortality, though this risk is only increased in patients with severe-to-severe acute RHF. Several predictors for RHF were identified, of which ratio of systolic pulmonary artery pressure to stroke volume was the strongest hemodynamic predictor. Coupling ratio of systolic pulmonary artery pressure to stroke volume with right atrial pressure may be most helpful in identifying patients at risk for severe-to-severe acute RHF.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3